Search results :

Hydroxybutyrate

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: N01AX11, N07XX04

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3
Headache postmarketing, 9% - 31% x x x
Dizziness 9% - 23% 4% x x x
Nausea 2.8% - 20% 3% x x x
Sleep disorder 9% x x
Pain 1% - 20% 1% x x
Infection 0% - 15% x x
Confusional state 7% x x
Albuminuria frequent x
Cystitis frequent x
Haematuria frequent x
Metrorrhagia frequent x
Pollakiuria frequent x
Urinary incontinence 5% x x
Vomiting 2% - 11% 1% x x x
Diarrhoea 3% - 4% 2% x x x
Asthenia 3% x x
Enuresis 3% - 7% 1% x x
Viral infection 0% - 9% x
Somnolence 1% - 8% 4% x x x
Paraesthesia 1% - 3% 1% x x
Muscle spasms 1% - 2% 2% x x
Tremor 0% - 5% 0% x x x
Abdominal pain upper 1% - 3% 2% x x
Disorientation 1% - 3% 1% x x
Anxiety 1% - 2% 1% x x x
Cataplexy 1% - 2% 1% x
Hyperhidrosis 1% - 3% 0% x x
Pain in extremity 1% - 3% 1% x
Dry mouth 1% - 2% 2% x
Disturbance in attention 0% - 4% 0% x x
Sleep paralysis 0% - 3% 1% x x
Syncope infrequent x
Micturition urgency infrequent x
Ageusia infrequent x
Irritability 0% - 3% 1% x
Feeling drunk 0% - 3% 1% x x
Arthralgia postmarketing x x
Hypersensitivity postmarketing x x x
Hypertension postmarketing x x x
Weight decreased postmarketing x x
Panic attack postmarketing x
Hangover postmarketing x x
Decreased appetite postmarketing x x
Memory impairment postmarketing x
Fluid retention postmarketing x
Vision blurred postmarketing x x
Abdominal pain x
Alopecia x
Amblyopia x
Amnesia x x
Anaemia x
Anorexia x x
Apnoea x
Arthritis x
Ataxia x
Back pain x x
Mental disorder x x
Bone disorder x
Chest pain x
Coma x
Connective tissue disorder x
Constipation x
Libido decreased x
Dehydration x
Depersonalisation x
Depression x
Dermatitis contact x
Dysgeusia x
Dysmenorrhoea x
Dyspepsia x
Dyspnoea x x
Ecchymosis x
Oedema x
Epistaxis x
Rash x x
Eye disorder x
Fatigue x
Faecal incontinence x x
Gastrointestinal disorder x x
Hallucination x x
Cardiac disorder x
Hiccups x
Hyperbilirubinaemia x
Hypercholesterolaemia x
Hyperglycaemia x
Hypernatraemia x
Hypoaesthesia x x
Hypocalcaemia x
Immune system disorder x
Incontinence x
Influenza x
Cramps of lower extremities x
Leukocytosis x
Mediastinal disorder x
Hypertonia x
Myoclonus x x
Nasal congestion x
Nasopharyngitis x
Nervous system disorder x x
Nervousness x x
Neuralgia x
Nightmare x
Palpitations x
Parasomnia x
Pharyngitis x
Polycythaemia x
Psychotic disorder x
Restless legs syndrome x
Rhinitis x
Convulsion x x
Sinusitis x x
Sleep apnoea syndrome x x
Snoring x
Somnambulism 0% - 3% 0% x x x
Stomatitis x
Withdrawal syndrome x
Suicide attempt x
Thirst x
Tinnitus x
Urinary tract disorder x x
Urticaria x x
Angiopathy x
Vertigo x x
Weight increased x
Chills x
Stupor x
Agitation x x
Apathy x
Oedema peripheral 0% - 3% 1% x x
Mouth ulceration x
Neck stiffness x
CNS depression NOS x
Creatinine increased x
Accidental injury x
Paranoid reaction x
Phosphatase alkaline increased x
Aspartate aminotransferase increased x
Alanine aminotransferase increased x
Malnutrition x
Unspecified disorder of skin and subcutaneous tissue x x
Myalgia x
Thinking abnormal x x
Abnormal dreams x x
Respiratory depression x x
Euphoric mood x
Enlargement abdomen x
Akathisia x
Initial insomnia x
Middle insomnia x
Suicidal ideation x
Hyperkinesia x
Lymphadenopathy x
Blood pressure increased x
Paralysis x
Balance disorder x
Sodium high x
Sweating increased 0% x
Acne x
Hyperuricaemia x
Infestation NOS x
Ear and labyrinth disorders x
Insomnia x x
Myasthenia 0% x
Paranoia x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

4-HYDROXYBUTANOIC ACID

Side effects:46
Source:FDA Structured Product Label

sodium oxybate / sodium oxybate

Side effects:81
Source:EMA

sodium oxybate / Xyrem

Side effects:105
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label